USP53 and carcinoma of esophagus: Cheng et al. [60] reported that USP53 inhibited the proliferation and growth of esophageal carcinoma cells in vitro and in vivo, and that USP53 activation by H3K27 acetylation modulates cell viability via the AMPK signaling pathway.